Not All Coronary Spasms Are the Same: Benefits of Acetylcholine

Patients with documented spasm to the coronary arteries present increased risk of myocardial infarction (MI) and repeat angiography, while patients with microvascular spasm are associated to recurrent angina. 

¿FFR de rutina en pacientes con síndrome coronario agudo?

Globally, the prognosis of all these patients continues to be favourable, even though acetylcholine testing might help distinguish one-another. 

Coronary spasm shows in up to 60% of patients with myocardial ischemia symptoms despite not presenting obstructive coronary lesions. 

This recent study published in JACC Interv retrospectively included consecutive patients with no obstructive coronary lesions undergoing acetylcholine testing for epicardial or microvascular spasm detection. 

Mortality, non-fatal MI, stroke, repeat angiography, recurrent symptoms, and quality of life of 736 patients were registered and followed up for 7.2 years.


Read also: IN.PACT AV ACCESS | Drug-Coated Balloons for Dialysis Fistulas.


Mortality in this followup period was 7.5%, non-fatal MI rate was 1.4%, and stroke reached 2.2%. 

Most patients reported recurrent angina (64%). This motivated repeat angiography (12%) which, same as before, showed no obstructive lesions.

Epicardial spasm was a predictor of non-fatal MI (HR: 14.4) and repeat angiography (HR: 1.7), while microvascular spasm predicted more symptoms (HR: 1.3).

Conclusion

The general prognosis of patients with coronary spasm is favourable. Acetylcholine testing helped identify patients with epicardial MI, with higher risk of non-fatal MI and repeat angiographies vs. patients with microvascular spasm associated to higher risk of recurrent angina. 

Original Title: Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing.

Reference: Andreas Seitz et al. JACC Cardiovasc Interv. 2020 Aug 24;13(16):1865-1876. https://doi.org/10.1016/j.jcin.2020.05.009.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...